UK’s NICE backs Medtronic’s MiniMed Paradigm Veo
Medtronic (NYSE:MDT) said today the U.K.’s National Institute for Health and Care Excellence issued positive guidance recommending the MiniMed Paradigm Veo insulin pump and integrated glucose sensor...
View ArticleTitan Medical closes $7.6m offering
Titan Medical (CVE:TMD) said today it closed its most recent offering, raising $7.6 million (CAD $10.5 million) by floating 11.7 million shares at 65¢ (CAD 90¢) per share to support its Sport robotic...
View ArticleBard touts data from Lutonix head-to-head study against MDT’s In.Pact
C.R. Bard (NYSE:BCR) subsidiary Bard Peripheral Vascular touted results showing no significant difference in a study pitting its Lutonix DCB against Medtronic‘s (NYSE:MDT) In.Pact DCB in treating...
View ArticleMassDevice.com +3 | The top 3 medtech stories for February 12, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleU.S., EU medical device associations push ‘regulatory cooperation’
Medtech industry advocacy groups on both sides of the Atlantic are pushing for regulatory cooperation in the Transatlantic Trade and Investment partnership, which is entering its 3rd year of...
View ArticleValtech touts German reimbursement win for Cardioband
Valtech Cardio said Tuesday it won reimbursement in Germany for its Cardioband Mitral Reconstruction System designed to treat mitral regurgitation in heart failure patients. The Cardioband system is...
View ArticleRTI Surgical inks deal with Oxford Performance Materials
RTI Surgical said yesterday it inked a deal with Oxford Performance Materials to license its OsteoFab platform for spinal applications. OPM’s OsteoFab is a next-generation implant manufacturing process...
View ArticleGN Store Nord’s shares jump as profits rise in fourth quarter
(Reuters) – Shares in Denmark’s GN Store Nord jumped as much as 15% on Friday after its financial results met forecasts following previous misses, legal problems and fears over the performance of one...
View ArticleAustralia’s Cochlear wants to buy govt hearing service, raises profit outlook...
(Reuters) – The Australian government said it is weighing a proposal from a consortium including hearing implant maker Cochlear Ltd. (ASX:COH) to buy a state-owned hearing service, a move likely to...
View ArticleLivaNova warns on possible endotoxin contamination in anesthesia equipment
LivaNova (NSDQ:LIVN) issued an urgent field safety notice concerning possible endotoxin contamination of unnamed surgical equipment related to anesthesia. LivaNova has not publicly released which...
View ArticleCardica pulls the trigger on 1-10 reverse split
Cardica (NSDQ:CRDC) said it is initiating a 1-for-10 reverse split of its common stock, effective today. Company stockholders approved a series of alternate amendments to effect a reverse stock split...
View ArticleEmergo analysis: Fewer 510(k) submissions from US medical device firms in 2015
By Stewart Eisenhart, Emergo Group In 2015, fewer US-based medical device companies submitted 510(k) applications to the Food and Drug Administration than at any point in the last five years. Also last...
View ArticleAnalyst doubts FDA’s estimate of fetal deaths linked to Bayer’s Essure
An analyst who examined the FDA’s adverse events website for cases involving the controversial Essure permanent contraception device made by Bayer (ETR:BAYN) said the federal safety watchdog likely...
View ArticleFresenius to settle dialysate lawsuits for $250m
Fresenius Medical Care (NYSE:FMS) said yesterday that its North American subsidiary agreed in principle to a $250 settlement of the multi-district litigation brought over its GranuFlo and NaturaLyte...
View ArticleMedtronic touts Solitaire stent retriever meta-analysis
The Solitare stent retriever Medtronic (NYSE:MDT) acquired for $50 billion last year when it bought Covidien is safe and highly effective when combined with standard care using the thrombolysis drug...
View ArticleIBM to pony up $2.6B for Truven Health Analytics
International Business Machine (NYSE:IBM) said today that it agreed to acquire Truven Health Analytics for $2.6 billion, marking IBM’s 4th major health-related acquisition since launching Watson Health...
View ArticleThe steady and successful climb of BaroNova
Hugh Narciso, CEO of BAROnova Welcome to the Medsider interview, a special new feature at MassDevice, which will appear regularly. All interviews are conducted by Scott Nelson, Founder, Medsider. We...
View ArticleStryker consolidation leads to 200-job expansion in Texas
Stryker (NYSE:SYK) is reportedly expanding its Stryker Communications operation in Texas as it consolidates other businesses in South Carolina and the Lone Star State. Kalamazoo, Mich.-based Stryker is...
View ArticleStealthy Vicarious Surgical raises $2.4m
Stealthy Vicarious Surgical said it raised nearly $2.4 million for the surgical virtual reality software it’s said to be developing. Cambridge, Mass.-based Vicarious reported the equity offering, which...
View ArticleU.S. securities regulator levels new charges in press release hacking case
(Reuters) — The SEC charged 9 new defendants in what it has called a more than $100 million international scheme to hack into newswires that distribute corporate press releases and to use stolen...
View Article
More Pages to Explore .....